Skip to content
AZ Pharma — Pharmaceutical Consultancy

Five questions to resolve before moving a process to a receiving site

Technology Transfer12 January 20266 min read

An effective transfer is not a document handover. These five questions surface the gaps that most often delay readiness, validation and commercial supply.

Technology transfer is where strategy meets the shop floor. When a product moves from a sending site to a receiving site, the visible artifacts — dossiers, batch records, specifications — are only the surface. Underneath sit decisions about process design, equipment capability, analytical control and people that determine whether the transfer lands on time.

In our work across receiving-site programs, the same categories of gap appear again and again. Resolving five questions early converts a hopeful timeline into a governed, evidence-based one.

The five questions

  1. 01Is the process knowledge complete and manufacturing-representative — or still evolving at the sending site?
  2. 02Does the receiving site's equipment, capacity and utility profile actually fit the process, at the intended batch size?
  3. 03Are analytical methods transferable as written, and who owns method bridging or revalidation?
  4. 04Are documentation architectures aligned — SOPs, batch records, specifications — so the receiving site can operate without translation?
  5. 05Is there a governance model with named owners, milestones, a risk register and defined readiness gates?

From answers to a plan

Each question maps to a workstream: strategy and due diligence, manufacturing readiness, the analytical and QA interface, and execution with verification. Where the answers are weak, the transfer plan should carry explicit gap-closure actions with owners and dates — not assumptions.

If you are preparing a transfer, a focused technical assessment in the early weeks is the highest-leverage investment available. It converts unknowns into a plan you can defend to regulators, partners and your own board.

AZ Pharma

AZ Pharma Pharmaceutical Consultancy

Pharmaceutical progress. From A to Z. Practical advisory for pharmaceutical manufacturing, quality and digital programs.

Get in touch

Next step

Turn insight into action.

Discuss how these practices apply to your site, program or portfolio with our senior advisors.

Discuss a Project